as on October 17, 2025 at 4:01 pm IST
Day's Low
Day's High
0.40%
Downside
1.00%
Upside
52 Week's Low
52 Week's High
40.23%
Downside
12.36%
Upside
as on October 17, 2025 at 4:01 pm IST
Market Cap
₹782.08 Cr
Return on Equity (ROE)
6.39
PE Ratio (TTM)
38.97
Return on capital employed (ROCE)
8.37
Industry PE ratio
41.74
Beta (LTM)
0.72
P/B Ratio
1.64
Dividend Yield
0PEG Ratio
10.25
Quarterly Earnings Growth YOY
93.78
EPS (TTM)
7.97
Sector
Pharmaceuticals
Book Value
128.75
Technical Analysis
Bullish
View Technical Analysis
as on October 17, 2025 at 4:01 pm IST
Sakar Healthcare Ltd in the last 5 years
Lowest (13.06x)
May 12, 2022
Today (38.97x)
October 17, 2025
Industry (41.74x)
October 17, 2025
Highest (71.76x)
January 24, 2024
Today’s Price to Earnings Ratio: 38.97x
Compare market cap, revenue, PE, and other key metrics of Sakar Healthcare Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 782.08 | 74.68% | 0.62 | 17 | 177 | |
NA | 13.33 | 57.33% | 0.00 | -1 | NA | |
NA | 111.10 | -10.14% | 0.70 | 6 | 318 | |
NA | 172.53 | 99.46% | 0.69 | -14 | 19 | |
BUY | 4,759.02 | -6.59% | 0.66 | 168 | 2,387 |
Search interest for Sakar Healthcare Ltd Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:14% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Sakar Healthcare Ltd.
Sakar Healthcare Ltd’s net profit jumped 93.78% since last year same period to ₹4.67Cr in the Q1 2025-2026. On a quarterly growth basis, Sakar Healthcare Ltd has generated -18.92% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, SAKAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Revenue Rich
Revenue is up for the last 5 quarters, 41.61 Cr → 53.13 Cr (in ₹), with an average increase of 5.8% per quarter
Retail Holding Up
Retail Investor have increased holdings from 21.85% to 22.48% in Jun 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.3% return, outperforming this stock by 101.9%
Promoter Holding Down
Promoters have decreased holdings from 53.58% to 52.86% in Jun 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 13.61% to 13.41% in Jun 2025 quarter
Price Dip
In the last 7 days, SAKAR stock has moved down by -4.2%
Profit Down
Netprofit is down for the last 2 quarters, 5.76 Cr → 4.67 Cr (in ₹), with an average decrease of 18.9% per quarter
Organisation | Sakar Healthcare Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
CEO | Sanjay S Shah. |
E-voting on shares | Click here to vote |
Sakar Healthcare Ltd share price today stands at ₹351.5 as on at the close of the market. Sakar Healthcare Ltd share today touched a day high of ₹355 and a low of ₹350.1.
Sakar Healthcare Ltd touched a 52 week high of ₹394.95 and a 52 week low of ₹210.1. Sakar Healthcare Ltd share price today i.e. is closed at ₹351.5, which is -11.00% down from its 52 week high and 67.30% up from its 52 week low.
Sakar Healthcare Ltd market capitalisation is ₹782.08 Cr as on .
To buy Sakar Healthcare Ltd shares, you need to follow these steps:
Sakar Healthcare Ltd trading volume is 13.01K as on . This means that 13.01K shares of Sakar Healthcare Ltd were bought and sold on the stock market during today's trading session.